Stay updated on Perseus Study: Daratumumab vs Standard in Untreated Myeloma Clinical Trial
Sign up to get notified when there's something new on the Perseus Study: Daratumumab vs Standard in Untreated Myeloma Clinical Trial page.

Latest updates to the Perseus Study: Daratumumab vs Standard in Untreated Myeloma Clinical Trial page
- Check4 days agoChange DetectedDeleted the 'Multiple Myeloma' condition entry and the 'MedlinePlus Genetics' related topic section from the page.SummaryDifference0.1%

- Check12 days agoNo Change Detected
- Check19 days agoChange Detected- Site revision updated from v3.4.3 to v3.5.0.SummaryDifference0.0%

- Check26 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3; no visible changes to study content or layout.SummaryDifference0.0%

- Check40 days agoChange DetectedAdded related topics: Multiple myeloma and MedlinePlus Genetics to the page.SummaryDifference0.1%

- Check55 days agoChange DetectedThe page shows a new site revision (v3.4.2) with recent date stamps (2026-02-10, 2026-02-09, 2026-01). The funding-status notice and older 2024 items were removed as routine maintenance.SummaryDifference0.6%

- Check62 days agoChange DetectedAdded a site-wide funding-status notice at the top of the page and updated the Publications section with a new citation while removing a prior ahead-of-print reference. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

Stay in the know with updates to Perseus Study: Daratumumab vs Standard in Untreated Myeloma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Perseus Study: Daratumumab vs Standard in Untreated Myeloma Clinical Trial page.